| Akt | protein kinase B |
| Apaf-1 | apoptosis protease-activating factor-1 |
| CD8+ T | cytotoxic T lymphocytes |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DOX | doxorubicin |
| ELISA | enzyme-linked immunosorbent assay |
| FDA | The Food and Drug Administration |
| H2DCFDA | 2′,7′-dichlorodihydrofluorescein diacetate |
| HER2 | human epidermal growth factor receptor 2 |
| IC50 | half-maximal inhibitory concentration |
| IFNγ | interferon gamma |
| IL-10 | interleukin-10 |
| IL-12 | interleukin-12 |
| IL-1β | interleukin-1β |
| IL-6 | interleukin 6 |
| JC-1 | 5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine, iodide |
| MMP | mitochondrial membrane potential |
| mTOR | mammalian target of rapamycin kinase |
| MTT | (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) assay |
| NK | natural killer cells |
| p53 | tumor protein P53 |
| PARP1/2 | poly ADP-ribose polymerase |
| PBS | phosphate buffered saline |
| PI3K | phosphoinositide 3-kinase |
| PPAR | peroxisome proliferator-activated receptors |
| ROS | reactive oxygen species |
| RTK | receptor tyrosine kinase |
| TNF | tumor necrosis factor |